by Kanchan Madan | Feb 25, 2022 | Press Releases
Today, the Food and Drug Administration accredited Farxiga (dapagliflozin) oral drugs to reduce the risk of kidney function decline, kidney failure, cardiovascular death, and hospitalization for heart failure in adults with continual kidney disease who are...
